• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Absorbed dose to the human adrenals from lodomethylnorcholesterol (I-131) "NP-59": concise communication.

作者信息

Carey J E, Thrall J H, Freitas J E, Beierwaltes W H

出版信息

J Nucl Med. 1979 Jan;20(1):60-2.

PMID:430180
Abstract

During the past 2 years, adrenal uptake percentage values were measured in more than 40 patients, using an external counting technique. They suggest that the absorbed dose to the adrenals is significantly less than 150 rads/mCIi previously estimated using concentration values from animal adrenals. The measured combined uptake percentage for both adrenals ranged from 0.15% to 0.52% in 21 patients without evidence of adrenal disease, with a mean of 0.33% +/- 0.1%; also from 0.22% to 1.5% in 22 patients with Cushing's disease, with a mean uptake of 0.78% +/- 0.35%. The absorbed dose to the adrenals was estimated to be 25 rads/mCi for patients without evidence of adrenal disease, and 57 rads/mCi for patients with Cushing's disease. Both values are calculated for the respective mean uptake percentages by using MIRD formalism.

摘要

相似文献

1
Absorbed dose to the human adrenals from lodomethylnorcholesterol (I-131) "NP-59": concise communication.
J Nucl Med. 1979 Jan;20(1):60-2.
2
[Measurement of percent uptake in the adrenal glands with 131I-adosterol (author's transl)].用¹³¹I-阿多甾醇测定肾上腺摄取百分比(作者译)
Kaku Igaku. 1980 Mar;17(2):219-27.
3
The relationship of serum lipids to adrenal-gland uptake of 6 beta-[131I]iodomethyl-19-norcholesterol in Cushing's syndrome.库欣综合征中血清脂质与肾上腺对6β-[¹³¹I]碘甲基-19-去甲胆固醇摄取的关系。
J Nucl Med. 1980 Nov;21(11):1069-72.
4
Failure to visualize adrenal glands in a patient with bilateral adrenal hyperplasia.双侧肾上腺增生患者肾上腺未显影。
J Nucl Med. 1980 Jan;21(1):49-51.
5
Adrenal scintiscanning with NP-59, a new radioiodinated cholesterol agent.使用新型放射性碘化胆固醇制剂NP-59进行肾上腺闪烁扫描。
Mayo Clin Proc. 1979 May;54(5):321-7.
6
The relationship of adrenal iodomethylnorcholesterol uptake to indices of adrenal cortical function in Cushing's syndrome.库欣综合征中肾上腺碘甲基去甲胆固醇摄取与肾上腺皮质功能指标的关系。
J Clin Endocrinol Metab. 1981 Jun;52(6):1062-6. doi: 10.1210/jcem-52-6-1062.
7
Adrenal scanning and uptake with 131I-6beta-iodomethyl-nor-cholesterol.
Radiology. 1978 Jul;128(1):157-61. doi: 10.1148/128.1.157.
8
The diagnosis of Cushing's syndrome using 131I-19-iodocholesterol uptake and adrenal imaging.
Clin Endocrinol (Oxf). 1980 Aug;13(2):145-9. doi: 10.1111/j.1365-2265.1980.tb01035.x.
9
[Scintigraphy of the adrenals using 131I-bimetrol].[使用¹³¹I-比美托洛尔进行肾上腺闪烁扫描术]
Med Radiol (Mosk). 1982 Nov;27(11):66-70.
10
Atlas of iodocholesterol scintigraphy (NP-59) in Cushing's syndrome with CT and MR correlation.
Clin Nucl Med. 1996 Feb;21(2):136-41. doi: 10.1097/00003072-199602000-00013.